n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, March 2nd, 2018

The QualityStocks
Daily Stock List

graphic
graphic

Federal Home Loan Mortgage Corporation (FMCC)

Investing, MarketWatch, Morningstar, 4-Traders, Capital Cube, and StockInvest.us reported on Federal Home Loan Mortgage Corporation (FMCC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Federal Home Loan Mortgage Corporation (also known as Freddie Mac) provides mortgage capital to lenders. Freddie Mac was created by Congress in 1970. It makes home possible for homebuyers, homeowners and renters across the nation. Federal Home Loan Mortgage Corporation (FMCC) is headquartered in McLean, Virginia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

FMCC’s mission is to provide liquidity, stability, and affordability to the U.S. housing market in all economic conditions. FMCC operates in the secondary mortgage market. FMCC keeps mortgage capital flowing through purchasing mortgage loans from lenders so they subsequently can provide more loans to qualified borrowers.

Fundamentally, FMCC purchases residential mortgage loans originated by lenders, and also invests in mortgage loans and mortgage-related securities.

The Company’s business lines include Single-Family – supports homebuyers and homeowners; Multifamily – supports renters; and Capital Markets - manages its investment portfolio. FMCC has made home possible close to 77 million times since 1970.

In 2017, FMCC provided $429 billion in mortgage funding. In addition, FMCC’s total guarantee portfolio grew to $2 trillion in 2017. Furthermore, the Company reported $5.6 billion in Net Income in 2017.

Yesterday, FMCC released the results of its Primary Mortgage Market Survey® (PMMS®). It shows the 30-year fixed mortgage rate increasing for the eighth-consecutive week.

The 30-year fixed-rate mortgage (FRM) averaged 4.43 percent with an average 0.5 point for the week ending March 1, 2018. This is up from last week when it averaged 4.40 percent. A year prior at this time, the 30-year FRM averaged 4.10 percent.

The 15-year FRM this week averaged 3.90 percent with an average 0.5 point. This is up from last week when it averaged 3.85 percent. A year prior at this time, the 15-year FRM averaged 3.32 percent.

The 5-year Treasury-indexed hybrid adjustable-rate mortgage (ARM) averaged 3.62 percent this week with an average 0.4 point. This is down a bit from last week when it averaged 3.65. A year prior at this time, the 5-year ARM averaged 3.14 percent.

Federal Home Loan Mortgage Corporation (FMCC), closed Friday's trading session at $1.55, down 0.64%, on 1,083,866 volume with 507 trades. The average volume for the last 60 days is 2,100,548 and the stock's 52-week low/high is $1.52/$3.24.

Table Trac, Inc. (TBTC)

FeedBlitz, BUYINS.NET, and M2 Communications reported previously on Table Trac, Inc. (TBTC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Table Trac, Inc. is a developer and provider of casino information and management systems. These systems automate and monitor the operations of casinos. The Company has systems installed in North America, South America, and Central America, and also the Caribbean. Established in 1995, Table Trac has its head office in Minnetonka, Minnesota. The Company also has a South America office in Envigado, Colombia.

The TableTrac™ table games management system is a patented solution. TableTrac™ provides table games managers and gaming operators with all the modules needed to manage and run a table games Pit. These include modules from credit fills and reporting to patron management and promotions.

Furthermore, the CasinoTrac™ casino management system provides a total complement of all the modules vital to ensure floor operations, real-time floor monitoring, daily revenue auditing, and managerial accounting and players club operations for any size casino.

In addition, the design of Table Trac’s KioskTrac™ is to reward play and boost visitation. KioskTrac™ provides operators with a vehicle to grow revenues. This is from “text-to-win” and campaigns, to email and direct mail.

Table Trac signed 12 new customer contracts in 2016. The Company expanded its presence in California, and Oklahoma. Additionally, Table Trac delivered its first systems in Texas and Washington.

At the end of 2016, the Company had casino management systems, table games management systems, and ancillary products installed with continuing support and maintenance contracts with numerous casino operators around the world. It also received gaming licenses in Colorado and Nevada.

Red Lake Gaming Enterprises has installed new casino management systems from Table Trac at its three first-class gaming properties in northern Minnesota. Red Lake Gaming Enterprises has provided premier gaming entertainment at its northern Minnesota casino locations since 1992.

Starting in 2004 they called on CasinoTrac systems to help. After a short hiatus, Table Trac has been selected to return to Red Lake Gaming and provide casino management systems.

Furthermore, Festival Casino has contracted with Table Trac to install their CasinoTrac online slot management system. This brings to six the number of Central America casinos selecting Table Trac's reliable and user-friendly system in 2017. Festival Casino is in Perez Zeledon, Costa Rica. CasinoTrac's system will add customer conveniences and a winning player club for the exotic Casino location.

Table Trac, Inc. (TBTC), closed Friday's trading session at $2.30, up 2.22%, on 2,500 volume with 1 trade. The average volume for the last 60 days is 1,452 and the stock's 52-week low/high is $0.51/$2.55.

DiaMedica Therapeutics, Inc. (DMCAF)

MarketWatch, Stockhouse, GuruFocus, Zacks, OTC Markets, Barchart, Marketwired, Penny Stock Hub, BusinessInsider, StreetInsider, The Street, and WeeklyHub reported on DiaMedica Therapeutics, Inc. (DMCAF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A clinical stage biopharmaceutical company, DiaMedica Therapeutics, Inc. concentrates on improving the lives of patients with neurological and kidney diseases associated with low KLK1 levels. The Company is developing unique treatments where there is significant unmet clinical need or where no present therapies are available with an emphasis on neurological and kidney diseases.

The Company previously went by the name DiaMedica, Inc. It changed its corporate name to DiaMedica Therapeutics, Inc. in December of 2016. The Company’s shares trade on the OTC Markets Group’s OTCQB.

DiaMedica Therapeutics is developing DM199. This is a recombinant (synthetic) human protein for patients suffering from neurological and kidney diseases.

DM199 has undergone clinical testing, which demonstrates its exceptional safety as a potential treatment for an array of disorders. DiaMedica is positing DM199 for the treatment of diabetic nephropathy and post-insult treatment from acute ischemic stroke (AIS).

Five clinical trials in more than 100 patients have been conducted with DM199. At present, DiaMedica Therapeutics is conducting a clinical trial designed to identify a dose of DM199 that is comparable to the human urinary and porcine approved versions in Asia. The results of the study will direct dosing for Phase II and Phase III clinical trials.

The Company believes DM199 has the potential to treat a wide array of clinical scenarios where re-establishing blood flow and lessening inflammation in patients is critical to preserving organ function. In 2017, DiaMedica Therapeutics advanced its deep understanding of DM199. In addition, the Company moved into the second phase of clinical trials. The DM199 Phase 2 REMEDY stroke study was started in fall 2017.

The DM199 Phase 1B bridging study for acute ischemic stroke dosing trial with DM199 was completed. This is an important milestone. It identified a therapeutic dose of DM199 that pharmaceutically matches the crude form of the protein, called Kailikang®. Kailikang® is approved in Asia. It has been used to treat more than 400,000 stroke patients.

In September 2017, the Australasian Stroke Trials Network (ASTN) announced its support for the Company’s Phase 2 REMEDY stroke study. ASTN is the key organization that promotes, facilitates, as well as coordinates stroke clinical trials in Australia and New Zealand.

Furthermore, DiaMedica Therapeutics identified chronic kidney disease (CKD) caused by Type 1 diabetes as the main indication for its first kidney disease trial. The Food and Drug Administration (FDA) has scheduled a face-to-face meeting with the Company in Q1 2018 to discuss its planned CKD trial and the regulatory path ahead. The intention of the meeting is to provide important confirmation and/or clarification of the required clinical path for CKD to be followed by initiation of a clinical study.

In February, DiaMedica Therapeutics announced the first patient enrollment, at the Royal Melbourne Hospital, Melbourne Australia, in its Phase 2 REMEDY trial assessing the safety, tolerability and markers of therapeutic efficacy of DM199 (recombinant human KLK1) in patients suffering from acute ischemic stroke. This trial will enroll about 60 patients. They will be randomized to receive either DM199 or placebo.

DiaMedica Therapeutics, Inc. (DMCAF), closed Friday's trading session at $0.2598, up 2.44%, on 242,231 volume with 51 trades. The average volume for the last 60 days is 81,984 and the stock's 52-week low/high is $0.1725/$0.345.

Ecosphere Technologies, Inc. (ESPH)

Buzz Stocks, Penny Pick Finders, PennyStockProphet, SmallCapVoice, Wall Street Resources, TheMicrocapNews, PennyStocks24, Planet Penny Stocks, SecretStockPromo, and StockOnion reported previously on Ecosphere Technologies, Inc. (ESPH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Ecosphere Technologies, Inc. is a development and Intellectual Property (IP) licensing company. It develops environmental solutions for worldwide water, energy, industrial, and agricultural markets. The Company helps industry boost production, reduce costs, and protect the environment through a portfolio of unique, patented technologies and exclusive and nonexclusive licensing opportunities across a broad array of industries and applications globally. Ecosphere Technologies is headquartered in Stuart, Florida.

Ecosphere has an extensive portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, as well as ecosystems. The Company’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®.

The Ecosphere technologies and products are available by way of numerous brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. Ecosphere’s objective is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.

The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a diverse range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment.

The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It employs hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates the Company’s patented Ozonix® water treatment technology.

The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.

Furthermore, Ecosphere has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.

Sea of Green Systems’ (SOGS) sublicensee in the agricultural industry, Gulf Coast Organics (GCO), signed an agreement with Wedgworth's, Inc., to be the exclusive distributor in Florida for its Amp Agronomy™ plant nutritional line. Wedgworth's provides custom blended agricultural plant nutrient products across Florida to help farms grow and prosper. CAVISONIX®, developed by SOGS and Ecosphere Technologies, uses ultrasonic cavitation to treat fertilizers for increased plant availability.

Wedgworth's is recognized as Florida's largest custom fertilizer dealer since 1932. Sea of Green Systems, Inc. (SOGS) is a subsidiary of Ecosphere Technologies. SOGS develops proprietary equipment, lighting and fertilizer solutions for the Precision Agriculture industry.

Ecosphere Technologies, Inc. (ESPH), closed Friday's trading session at $0.014, up 0.36%, on 233,785 volume with 7 trades. The average volume for the last 60 days is 230,044 and the stock's 52-week low/high is $0.0083/$0.045.

Rennova Health, Inc. (RNVA)

Barchart, Preferred Stock Channel, Street Insider, StockTwits, InvestorsHub, and Stockhouse reported on Rennova Health, Inc. (RNVA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Rennova Health, Inc. is a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers. The Company opened its first rural hospital in Oneida, Tennessee on August 8, 2017. Rennova Health delivers an efficient, effective patient experience and first-rate clinical outcomes. The Company is based in West Palm Beach, Florida. Rennova Health has its Medytox Diagnostics subsidiary.

Essentially, Rennova Health is a single-source healthcare solutions company. It centers on serving essential healthcare categories, particularly those with unmet needs and major opportunities for innovation-driven solutions. The Company develops and operates progressive businesses, systems and services to support better treatment outcomes, more cost-effective patient care, and optimized revenue streams.

Rennova Health’s solutions include industry-leading diagnostic laboratory testing and analytics for precision medicine, and specialized and streamlined EHRs and other essential software services. Its solutions also include complete medical billing and financial services for enhanced revenue cycle management.

The Big South Fork Medical Center opened under Rennova Health’s ownership with services that include a 24/7 emergency department along with radiology services that include X-ray, CT scan and ultrasound. Furthermore, other available services include a laboratory, respiratory therapy, physical therapy, a medical/surgical unit, and swing beds.

Rennova’s Medytox Diagnostics subsidiary owns and operates five high-complexity CLIA-certified labs strategically located across the nation. These labs specialize in urine drug testing for prescription medications, drugs of abuse and complete pain medication testing.

The labs also provide testing services in the areas of clinical chemistry, toxicology, hematology, immunology, serology, bacteriology and esoteric testing services, including neurotransmitter testing, with a wide array of sampling options that include the Company’s proprietary methodology.

Rennova Health also has its comprehensive medical billing services company, Medical Billing Choices (MBC). MBC operates as the in-house billing company for all Rennova Health businesses and labs.

Recently, Rennova Health announced that its flagship Laboratory, EPIC Reference Labs, Inc. (EPIC), successfully met the Laboratory Accreditation Program Standards for Accreditation from the College of American Pathologists (CAP). Since 2015, EPIC has been operating as a urine toxicology testing laboratory in Riviera Beach, Florida.

Under the CAP Accreditation, EPIC Reference Labs has been accredited for the All Common, Chemistry, Director/Organizational Assessment, Hematology, Immunology, Laboratory Central, Special Chemistry, Toxicology and Urinalysis testing services. In addition, subspecialty accreditation was granted for Endocrinology, General Immunology, Hematology, Routine Chemistry, Toxicology, Urinalysis and Syphilis Serology.

At the end of January, Rennova Health announced that it entered into a definitive asset purchase agreement to acquire an acute care hospital in Jamestown, Tennessee. The hospital, known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc. (CYH).

Tennova Healthcare - Jamestown is a fully operational 85-bed facility. The expectation is that this transaction will close in Q2 of 2018, subject to customary regulatory approvals and closing conditions.

Currently, Rennova Health operates in three synergistic divisions. One is clinical diagnostics via its clinical laboratories. The second is supportive software solutions to healthcare providers. This includes electronic health records (EHR), laboratory information systems (LIS) and medical billing services. The third is the recent addition of the hospital in Tennessee.

Rennova Health, Inc. (RNVA), closed Friday's trading session at $0.0053, up 6.00%, on 36,132,194 volume with 555 trades. The average volume for the last 60 days is 9,311,377 and the stock's 52-week low/high is $0.004/$54.00.

Newgioco Group, Inc. (NWGI)

OTC Markets, TradingView, MarketWatch, and LAST10K reported on Newgioco Group, Inc. (NWGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Newgioco Group, Inc. is a betting software technology business. The Company provides regulated leisure lottery and gaming products and services by way of licensed subsidiaries based in Europe. Newgioco Group, together with its wholly-owned subsidiaries, is a fully-licensed and integrated gaming software technology enterprise.

Listed on the OTCQB, Newgioco Group has its headquarters in Toronto, Ontario. The Company also has an office in Rome, Italy. The Company was previously known as Empire Global Corp. It changed its name to Newgioco Group, Inc. in July of 2016.

Newgioco Group conducts its business chiefly through retail neighborhood betting shops and an internet-based gambling and sports betting software platform under the registered brand Newgioco, through its licensed website www.newgioco.it located in Italy.

The Company has acquired Multigioco Srl. This is a licensed gaming operator headquartered in Rome. Newgioco Group’s plan is to aggressively go after attractively priced, fragmented, and profitable gaming operators in Italy. Its goal is to become a top-tier gaming operator over a five-year investment time horizon.

Newgioco provides its clients a comprehensive set of leisure gaming products and services. These include sports betting, virtual sports, online casino, poker, bingo, lottery, interactive games and slots, and an innovative betting platform providing Business-to-Business (B2B) and Business-to-Consumer (B2C) bet processing.

In late January, Newgioco Group announced the signing of four new online gaming operators. This further expands Newgioco's distribution network in Italy.

The four new web skins include www.clubgames.it (Region: Sardegna/Lazio); www.mixbet.it (Region: Campania/Puglia); www.imperialbet.it (Region:Sicilia); and www.quibet.it (Region: Calabria).

The new operators expand Newgioco Group’s fast-growing online distribution to regions not earlier covered by the Company’s webshop locations. This brings the total retail stores to about 1,300. In addition, it increases the number of websites distributing the Newgioco brands to eight.

In February, Newgioco Group announced the launch of NG PAY payment gateway under a licensing agreement with Euronet Worldwide, Inc. headquartered in Leawood, Kansas. The Company's secure payment gateway by way of Euronet will be available on the www.ngpay.it website. It will make a broad assortment of integrated payment, pre-paid, remittance and reload solutions available to its registered online customers, partners, webshops, and retail stores.

Newgioco Group reported strong transactions growth for Q4 2017. It reported that sport betting volumes in Q4 2017 increased 25 percent on a year-over-year basis to $32 million. Gross gaming profits were $6.5 million in Q4. This is the highest for any quarter in Newgioco’s history. Gross gaming profits increased 82 percent on a year-over-year basis.

Newgioco Group, Inc. (NWGI), closed Friday's trading session at $0.40, even for the day, on 10,000 volume with 2 trades. The average volume for the last 60 days is 27,340 and the stock's 52-week low/high is $0.085/$0.9499.

Tautachrome, Inc. (TTCM)

MarketWatch and InvestorsHub reported on Tautachrome, Inc. (TTCM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tautachrome, Inc. is an emerging growth enterprise in the developing digital imagery technology sector. It is a developer of software applications for trustable and engageable digital pictures and videos. The Company’s chief priority is developing its branded KlickZie platform. An Internet technology development business, Tautachrome is headquartered in Oro Valley, Arizona and has operations in the United States and Australia.

The KlickZie platform will turn smartphones into trusted imagers. This means the pictures and videos they capture can be verified as original, untampered, and un-photoshopped. Additionally, the KlickZie platform creates imagery that is interactive and engageable.

The KlickZie platform will serve as the world’s first imagery-based social website network. Through clicking or tapping on a KlickZie'd image, users can communicate with the image's author or others presently looking at the image, in an engaging way.

Basically, KlickZie is an image verification service for smartphones. It brings trust back to digital imagery. In addition, KlickZie turns the smartphone into a reliable image source. Smartphone users download KlickZie’s free software to take their pictures and videos.

KlickZie pictures and videos are invisibly marked, stored in the KlickZie cloud, and guaranteed free from manipulation. The cloud will certify the authenticity of any KlickZie picture or video.

Tautachrome also has pioneering patents pending. These include Talk-to-the-Picture social networking and the abovementioned trustable imagery-based interaction.

Tautachrome is establishing a development team of providers to develop a blockchain based cryptocurrency ecosystem with a cryptotoken designated “KLK”. It will be the currency of the KlickZie community internationally.

This will permit KlickZie users to monetize their pictures and videos. As a result, it will enable the buying, selling, and licensing of KlickZie pictures and videos everywhere.

Recently, Tautachrome announced that it hired the Pryor Cashman law firm in New York to lead its work to register its KLK cryptotoken sale with the Securities and Exchange Commission (SEC). Mr. Ali Panjwani with support from his colleagues Mr. Jeff Alberts and Mr. Mike Campoli is leading the Pryor Cashman work team.

This team has considerable cryptotoken knowledge. In addition, it has significant experience with SEC registration. This includes past employment with the SEC in this area.

Tautachrome Chief Executive Officer, Dr. Jon N Leonard, said, “I have directed the Pryor Cashman team to work with the SEC’s crypto currency task force to ensure that our vision for a KLK cryptotoken-based ecosystem, able to monetize the world’s smartphone imagery becomes a reality, and that it is fully compliant with SEC regulations. We appear to be breaking new ground in this work. But I believe that the social and economic potential of this effort is so great, that every effort is justified.”

Tautachrome, Inc. (TTCM), closed Friday's trading session at $0.0077, down 8.33%, on 1,772,274 volume with 18 trades. The average volume for the last 60 days is 916,676 and the stock's 52-week low/high is $0.0024/$0.03.

Mikros Systems Corp. (MKRS)

OTCEquity, PennyStocks24, AwesomeStocks, Wall Street Mover, PricelessPennyStocks, Promotion Stock Secrets, Marketbeat.com, Fast Money Alerts, Actual Gains, AddictivePennyStocks, Chatter Box Stocks, StockLockandLoad, PennyStockRumors.net, StockRockandRoll, StockBomb.com, ResearchOTC, and OTPicks reported on Mikros Systems Corp. (MKRS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mikros Systems Corp. is a provider of advanced maintenance and monitoring solutions for mission-critical systems. The Company is an advanced technology enterprise that designs and manufactures specialized electronic systems for the Department of Defense. Its chief business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. The Company is headquartered in Princeton, New Jersey, and has its Manufacturing and Depot Center in Largo, Florida.

Mikros produces advanced maintenance systems for the Navy. These include the ADEPT Maintenance Automation Workstation and the ADSSS Condition Based Maintenance system for the Littoral Combat Ship. ADEPT systems are in use daily for performance optimization of advanced radar systems.

The Company has developed, delivered, and installed military-grade equipment to Federal customers’ for more than 30 years. Its capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering.

Mikros Systems’ Lifecycle Support capability is focused on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to accomplish the highest levels of system readiness. The Company purchased certain software products, intellectual property (IP) and related assets from VSE Corp. The main software programs purchased by Mikros are the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs.

The Diagnostic Profiler software is used globally by many multinational companies for optimized maintenance of varied product lines. Diagnostic Profiler is also used by the U.S. Air Force for depot test programs.

Prognostics Framework is used by the U.S. Army for many missile defense systems. These software products provide Mikros Systems with the opportunity to service commercial customers and additional Department of Defense customers outside the Navy.

In September 2017, Mikros Systems announced that it received the second production order awarded under its recent multi-year $35M contract with the Naval Surface Warfare Center in Crane, IN. This order covers new production deliveries of Mikros' Adaptive Diagnostic Electronic Portable Testset (ADEPT). It is valued at $2.4 million. The ADEPT units will be produced at the Mikros Manufacturing and Depot Center in Largo, FL.

Mikros has successfully completed the first ship and shore installation and testing of its ADEPT Distance Support Sensor Suite (ADSSS) on the Littoral Combat Ship USS INDEPENDENCE (LCS 2). As installed on LCS 2, ADSSS will utilize the Company’s proprietary model-based Prognostics Framework technology to monitor combat system elements to detect and predict on-ship system failures and apply predictive analytics to on-shore systems to detect broader maintenance trends and patterns across the fleet.

ADSSS Program Manager, Lori Ogles, said earlier in December, "Mikros has been a proud partner of the U.S. Navy for over fifteen years. We are honored to continue to support the readiness of U.S. Navy combat systems with our condition-based maintenance solution and we look forward to expanding the ADSSS technology to additional LCS and U.S. Naval platforms."

Mikros Systems Corp. (MKRS), closed Friday's trading session at $0.385, up 1.05%, on 4,600 volume with 6 trades. The average volume for the last 60 days is 13,648 and the stock's 52-week low/high is $0.3101/$0.63.

American Cannabis Company, Inc. (AMMJ)

Cannabis Financial Network News, Stock News Now, Wealth Insider Alert, Market Intelligence Central, Wall Street Daily, Promotion Stock Secrets, CFN Media Group, The Street, Marketbeat.com, and TheOTCInvestor reported on American Cannabis Company, Inc. (AMMJ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, American Cannabis Company, Inc. is a full-service Business-to-Business (B2B) consulting solutions provider. It is also a seller of ancillary products to the cannabis industry. American Cannabis provides end-to-end solutions to existing and ambitious participants in the cannabis industry. The Company supports its clients from concept to creation, commercialization and continuing operations. American Cannabis Company has its corporate headquarters in Denver, Colorado.

American Cannabis Company provides complete consulting management and products solutions to the regulated cannabis markets. It uses its industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure, and establish operational best practices.

The Company has its proprietary product named SoHum Living Soils™. SoHum Living Soils™ is a proprietary "just add water" growing medium. It contains 100 percent natural ingredients.

SoHum Living Soils™ provides the plant a total buffet of macro/micro nutrients to attain genetic optimization of the cannabis plant. SoHum Living Soils® won the 2017 High Times STASH award for "Best Potting Mix."

Moreover, American Cannabis owns The Cultivation Cube™, and The High Density Cultivation System™. These are proprietary cultivation products.

Regarding Products, American Cannabis provides a comprehensive organic grow system, retail solutions (the Satchel™), and grow components. It also provides group purchasing discounts for supplies.

The Satchel is a child-proof, tamper-proof vessel for dispensaries. The Satchel™ may be used by dispensaries to assemble orders and ensure the proper post sale handling of cannabis per each State's legislation.

Concerning Consulting, the Company provides application support, business planning, site selection, and regulatory compliance, among other services. Regarding Management, American Cannabis provides yield analysis, staffing, business coaching, and staff training and education, and more.

In early January 2018, American Cannabis Company announced that it secured a consulting contract with California City Cannabis Company in the State of California. In association with the consulting agreement, it will acquire an equity stake in California City’s project that is now non-operational and in the development stage.

As proposed, California City has plans to build a cannabis business park in California City, California. The plans for the park include a total of 20 to 25 acres of land set aside for development, and the potential hosting of future extraction, cultivation, as well as distribution businesses.

Recently, American Cannabis Company announced that it secured a consulting contract with Cloud 9 Apothecary in California. In association with the consulting agreement, it will acquire an equity stake in Cloud 9’s project that is presently non-operational and in the development stage.

The project will be built-out and completed in Desert Springs, California. It will consist of a closed-loop greenhouse containing a 22,000 square foot canopy of premium cannabis cultivars.

American Cannabis Company, Inc. (AMMJ), closed Friday's trading session at $0.8799, up 1.14%, on 97,523 volume with 120 trades. The average volume for the last 60 days is 597,430 and the stock's 52-week low/high is $0.35/$1.53.

Legacy Education Alliance, Inc. (LEAI)

Marketbeat, DSR News, PHUB News, Fortune Stock Alerts, RedChip, Stock Commander, and PennyPickAlerts reported previously on Legacy Education Alliance, Inc. (LEAI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Legacy Education Alliance, Inc. is a foremost worldwide provider of practical, high-quality, and value-based educational training. This training is on the topics of personal finance, entrepreneurship, real estate, and financial markets investing strategies and techniques. The Company’s devotion is to providing quality financial education.

Formed in 1996, Legacy Educational Alliance has headquarters in the United States, Canada, and the United Kingdom (UK). Legacy is an international business. It has cumulatively served greater than two million students from more than 150 nations and territories over the course of its operating history. Legacy Educational Alliance’s U.S. office is in Cape Coral, Florida.

The Company provides its training through an assortment of brands. These include Trade Up Investor Education™; Rich Dad® Education; Rich Dad® Stock Education; Making Money from Property with Martin Roberts™; Brick Buy Brick™; Building Wealth; Robbie Fowler Property Academy™; Women in Wealth™; and The Independent Woman™.

The Rich Dad® Stock Education training brand helps its students become astute investors who understand how to create winning trades and potential profits in any market condition. The Making Money from Property with Martin Roberts™ brand provides a property-based curriculum centered on how and why to buy property at auction.

The design of Robbie Fowler Property Academy™ is to teach investment strategies people can use to attain a clear path towards long-term wealth. The Independent Woman™ is a leader in the effort to provide educational training, seminars, and services designed to help women build their financial intelligence.

Rich Dad® Education provides students with extensive instruction and mentoring in real estate and financial instruments training in the U.S., Canada, and the UK. The Women In Wealth™ brand seeks to empower women with a strong financial education and help them in discovering the power of real estate investing to create cash flow and build financial independence.

The Trade Up Investor Education™ brand underwent development in partnership with Investor's Business Daily®. Students’ are provided educational training designed to help them build their knowledge of stock and options trading. The Brick Buy Brick™ brand introduces its students to the tools and strategies employed by successful investors to become financially free through real estate investing.

Recently, Legacy Education Alliance announced that it entered into a definitive agreement with its licensor of Rich Dad branded intellectual property (IP) to extend the term of its present license agreement through September 1, 2019. Due to this extension, Legacy will continue to be able to market globally its set of products and services under the Rich Dad Education brand.

Last month, Legacy Education Alliance announced that it entered into an agreement with Get Motivated Events, LLC. The Company will market its Legacy Education™ branded real estate and paper assets training programs at Get Motivated! large stage business seminars produced by Get Motivated Events.

Get Motivated! Business Seminars provide attendees the opportunity to hear from top figures in sales and marketing, negotiation, personal development, motivation, and more. Legacy Education Alliance is scheduled to participate in The Get Motivated! Business Seminar in Atlanta, Georgia on March 22, 2018.

Legacy Education Alliance, Inc. (LEAI), closed Friday's trading session at $0.4444, up 1.00%, on 500 volume with 1 trade. The average volume for the last 60 days is 41,738 and the stock's 52-week low/high is $0.2303/$0.60.

graphic

The QualityStocks
Company Corner

graphic
graphic

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.9207, up 33.63%, on 2,493,152 volume with 1,250 trades. The stock’s average daily volume over the past 60 days is 1,779,521, and its 52-week low/high is $0.177/$1.95.

InMed Pharmaceuticals Inc. (CSE:IN; OTCQB:IMLFF), announced today that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to list its common shares ("Common Shares") on the TSX.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Receives Conditional Approval to List on the Toronto Stock Exchange

InMed Closes Over-Subscribed C$9.4 Million Financing

CannabisNewsWire Announces Publication on Increased Investment Activity in Cannabis

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF). Today, Global Hemp Group, Inc. closed trading at $0.15, up 15.38%, on 234,108 volume with 30 trades. The stock’s average daily volume over the past 60 days is 434,193, and its 52-week low/high is $0.0115/$0.316.

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is employing a “Soil-to-Shelf” strategy for development of hemp in Canada and the United States. An article discussing the company reads: “Global Hemp plans to apply for a license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop in New Brunswick.” To view the full article, visit: http://cnw.fm/r3glT

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Hemp Group, Inc. Company Blog

Global Hemp Group, Inc. News:

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) Pursues its Share of America’s Prosperous Cannabis Industry

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) Pursuing Opportunities in America’s ‘New Billion-Dollar Crop’

CannabisNewsBreaks – Why Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is “One to Watch”

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.05762, off by 0.66%, on 4,531,097 volume with 336 trades. The stock’s average daily volume over the past 60 days is 10,233,113, and its 52-week low/high is $0.0132/$0.415.

Specialized holding company SinglePoint, Inc. (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. To view the full interview, visit: http://cnw.fm/31TnR. To view the full press release, visit: http://cnw.fm/KDZz3

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

CannabisNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Recent LOI to Acquire Stake in MTH Development Group on MoneyTV

SinglePoint, Inc. (SING) Featured in Extensive Superb Crew Interview of Smart Cannabis

SinglePoint Signs LOI to Acquire $1,000,000 stake in California Cannabis Cultivation Land

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.655, up 0.77%, on 40,076 volume with 29 trades. The stock’s average daily volume over the past 60 days is 194,708 and its 52-week low/high is $0.40/$1.83.

Chineseinvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang spoke of the company’s history and the recent focus on CBD oil products and cryptocurrency investor education today, on MoneyTV with Donald Baillargeon. The television program can also be viewed online immediately at www.moneytv.net.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News

MoneyTV with Donald Baillargeon, 3/2

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Releases Stock Dividend Details Regarding Spinoff of Hemp-related Assets

ChineseInvestors.com, Inc. (CIIX) Recognizes Untapped CBD Market for Chinese-Speaking Individuals

Petrogress, Inc. (PGAS)

The QualityStocks Daily Newsletter would like to spotlight Petrogress, Inc. (PGAS). Today, Petrogress, Inc. closed trading at $0.026, even for the day, on 97,429 volume with 11 trades. The stock’s average daily volume over the past 60 days is 207,747, and its 52-week low/high is $0.017/$0.072.

Diversified marine transport and offshore services company Petrogress, Inc. (OTC: PGAS) seeks to utilize its shipping expertise to enter U.S. to enter the U.S. liquefied natural gas (“LNG”) export market. An article discussing the company reads: “PGAS has set up a number of American business units to join the export extravaganza.” To view the full article, visit: http://nnw.fm/3uZa3

Petrogress, Inc. (PGAS) founded in 2009, owns and operates a fleet of tankers from its base in the historic Port of Piraeus, Greece, through a series of Marshall Islands subsidiaries. The company is an international merchant of petroleum products which includes reliably marketing and trading crude oil, distillates, and refined products off the coast of West Africa. The company also operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana. It is actively seeking expansion opportunities, including in operating and developing natural gas production and transmission facilities along with LNG processing in the U.S., refinery operations in north and west Africa, and the transport and sales of LNG in Europe.

Petrogress has created a diversified revenue stream, giving it a significant advantage over similar companies working in the oil and gas shipping arena. A case in point is the recent formation of "PG Cypyard & Offshore Service Terminal Ltd. ("Cypyard"), through the company's wholly owned subsidiary, Petrogress Int'l, LLC. Cypyard is concluding negotiations for an operations and management agreement covering ports in Hellenic Cyprus, including the Port of Limassol, directly with the Cyprus Ports Authority. Current plans include a long-term lease with renewal options covering all in-place port facilities, including floating dock and dry dock areas, with cranes and scaffolding, construction and repair workshops and storage, and complete on-site administrative and office space.

"I think the opportunities there are great, and dealing directly with partners in government has numerous benefits," said Christos P. Traios, president of Petrogress Inc. in a news release announcing the venture. The recent appointment of two industry experts to the Petrogress Advisory Board is expected to help the company capitalize on future growth opportunities while simultaneously developing a comprehensive U.S. and international lobbying and government outreach program to facilitate business plans in the U.S., European Union and Africa.

Additional Petrogress Inc. subsidiaries are:

  • Petrogress Co. Ltd., an international merchant of petroleum products that combines regional market knowledge with over 20 years of excellent shipping experience.
  • Petrogress Co. Ltd., an international merchant of petroleum products that combines regional market knowledge with over 20 years of excellent shipping experience.
  • Petrogress Oil & Gas Energy Inc., which has expansion plans through a supply of liquified natural gas located in the oil fields of Texas with an eye toward exporting LNG to Mediterranean markets.

Petrogress continues to "adjust its sails" in order to meet new challenges. Opportunities include upstream oil resources and exploration, the addition of more product fleet carriers, downstream movement of petroleum products from refineries to finished sales, and sea transportation of liquified natural gas. A closely followed economist, Jim O'Neill, states that oil prices could spike more than 25% in the next year. O'Neill, now an economics professor at the University of Manchester, says the market is finally waking up to the fact that global economic growth is gaining momentum and likely expanding at 4 percent or higher. That means there will be more demand for oil, the article states, which translates into brighter days ahead for companies like Petrogress. Disclaimer

Petrogress, Inc. Company Blog

Petrogress, Inc. News:

NetworkNewsBreaks – Petrogress, Inc. (PGAS) Poised to Capitalize on Growing U.S. LNG Export Market

Petrogress, Inc. (PGAS) Continues Global Expansion in Nigeria

Petrogress, Inc.’s (PGAS) Texas Operations Get Underway as U.S. Eyes Number Three Spot in Global LNG Exports

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0229, up 7.51%, on 9,152,450 volume with 286 trades. The stock’s average daily volume over the past 60 days is 13,997,348, and its 52-week low/high is $0.0141/$0.16.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Blockchain Takes Center Stage in Payment Processing Revolution," featuring Global Payout, Inc. (GOHE). To hear the NetworkNewsAudio version, visit: http://nnw.fm/lGTp4. To read the original editorial, visit: http://nnw.fm/FwcS8

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on Global Payout, Inc. Revolutionizing Payment Processing with Blockchain

NetworkNewsWire Announces Publication on Contenders Transforming Payment Processing with Blockchain

Cannabis: The New California Gold Rush Brings Expansion to GOHE MoneyTrac's PotSaver Brand

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF). Today, Choom Holdings Inc. closed trading at $0.6228, off by 0.59%, on 89,326 volume with 53 trades. The stock’s average daily volume over the past 60 days is 52,926, and its 52-week low/high is $0.125/$0.8612.

With the recent announcement of its national retail dispensary rollout strategy, Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is providing individual entrepreneurs the opportunity to capitalize on the expected business boom by registering for their own Choom™ store (http://cnw.fm/HCGq3). The company announced this morning that it had received processing approval from The Depository Trust Company (“DTC”) of New York and, as a result, is now DTC eligible. To view the full press release, visit: http://nnw.fm/3qM8d

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s "Choom Gang," a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with "choom," the local's term for marijuana. Choom's trademark slogans pivot off another unconventional phrase ("Say Hello to…"), bringing a heady dose of good times and good friends together as the company invites investors to "Say Hello to Choom™" as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company's first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom's initial license applications to ensure the company's readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company's character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1's revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic "Aloha" vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company's growth strategy. Get ready to "Say Hello" to opportunity, good times and good friends with Choom™. Disclaimer

Choom Holdings Inc. Company Blog

Choom Holdings Inc. News:

NetworkNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Receives Processing Approval from Depository Trust Company

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Opens the Door for Canadian Entrepreneurs with Dispensary Rollout Strategy

Choom Crystallizes Commitment to Recreational Branding with New Hire -- CFN Media

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.10689, up 1.55%, on 55,938 volume with 52 trades. The stock’s average daily volume over the past 60 days is 60,918, and its 52-week low/high is $0.015/$1.8892.

Petroteq Energy Inc. (TSXV:PQE) (OTCQX:PQEFF) (Frankfurt:PQCF) announces it has received a subscription from an arm’s length party for 107,525 common shares for gross proceeds of US$100,000. The shares will be issued upon receipt of conditional approval from the TSX Venture Exchange (the “Exchange”).

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq Energy Announces Proposed Issuances of Securities

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Introduces Blockchain Innovation to Reduce Oil & Gas Industry Transaction Costs

Petroteq Energy Launches Communication Strategy

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.33, off by 4.24%, 5,500 volume with 2 trades. The stock’s average daily volume over the past 60 days is 15,618, and its 52-week low/high is $0.01/$0.80.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PreveCeutical Medical Inc. (OTCQB:PRVCF) (CSE:PREV) (FSE:18H), a client of NNW and health sciences company that develops innovative preventive therapies utilizing organic and nature identical products. To view the full publication, titled “Gene Therapy Holds Out Hope for Diabetics,” visit: http://nnw.fm/7lg0F.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on PreveCeutical Medical Inc.'s Focus on Gene Therapy Treatments

NetworkNewsWire Announces Publication on Exciting Treatment Advancements Through Gene Therapy

Gene Therapy Holds Out Hope for Diabetics

Reign Sapphire Corp. (RGNP)

The QualityStocks Daily Newsletter would like to spotlight Reign Sapphire Corp. (RGNP). Today, Reign Sapphire Corp. closed trading at $0.12455, off by 9.42%, on 101,000 volume with 19 trades. The stock’s average daily volume over the past 60 days is 62,157, and its 52-week low/high is $0.0519/$0.325.

Reign Sapphire Corp. (OTCQB: RGNP), headquartered in Beverly Hills, California, is an ethical and sustainable jewelry company with three niche brands: Reign Sapphire, Coordinates Collection and Le Bloc. The three brands offer unique, quality craftsmanship pieces designed to capture memories. They are sold through a commission-based affiliate program that utilizes influencers, email campaigns and promotions, as well as digital advertisement and events.

Reign Sapphire Corp. (RGNP), is a direct-to-consumer, custom and branded jewelry company headquartered in Los Angeles, California. Reign's mission is to provide ethical and sustainable jewelry direct to the modern consumer, marketed through sophisticated digital initiatives that speak directly to individuals through social media channels and personalized promotions. The company's lean operating model ensures expenses are linked to order flow with flexible production schedules targeting just-in-time delivery, which in turn reduces or eliminates commodity risk. Reign is a member of the American Gem Trading Association, which is committed to fair trade and processing of gemstones.

Reign Sapphire Corp. owns and operates three divisions: Reign Brands, Reign Ventures and Reign Blockchain. Reign Brands features four unique, niche jewelry brands with separate social media followings:

  • Reign Sapphires: Ethically produced, millennial-targeted sapphire jewelry sourced from Australia.
  • Coordinates Collection: Custom jewelry inscribed with location coordinates commemorating life's special moments.
  • Le Bloc: Classic, customized jewelry.
  • ION Collection by Jen Selter: Athleisure jewelry brand.

Reign Ventures is the company's joint venture platform for investment and development of jewelry technology-related products.

Reign Blockchain authenticates its sapphires as conflict-free, allowing customers to wear products created by a company that shares their beliefs in human dignity and environmental stewardship. In 2018, Reign Blockchain is preparing to conduct an initial coin offering (ICO) for ReignCoin, subject to regulatory approval. ReignCoin will serve as Reign's cryptocurrency as part of a blockchain-based loyalty reward program.

The company's products are sold through a commission-based affiliate program that is supported by personalized email campaigns and promotions, celebrity promotion and gifting, digital advertising based on keyword purchases and sponsored ads, and creative publicity events and media outreach to attract maximum exposure. The successful launch of a company-wide social media influencer campaign across all its retail brands boosted Reign's Instagram, Twitter and Facebook followings by double digits within the first three weeks of going live.

Reign continues to seek out international partnerships, adding to the success it has already achieved in the Middle East, where its flagship store is in the Dubai Mall. The company recently teamed up with the original founder of its Coordinates Collection brand, Owen de Vries, who will lead its Europe and United Kingdom sales efforts. The Netherlands-based operation will proliferate Reign point-of-sales that are adapted for local language, digital marketing and customer service.

Reign Sapphire Corp. is led by president and CEO Joseph Segelman, who has also served on the board of directors since December 2014. Segelman earlier served as the Chief Executive Officer and managing director of Australian Sapphire Corporation, Shefa Mining Corporation and Spencer Lloyd & Associates. He is an experienced marketing and operations professional with over 20 years of experience in logistics and marketing, and extensive experience in the Australian mining and gem industry. He is also a director and board member of OBK (a Sydney, Australia, based charity) and a Captain (Chaplain) in the Australian Army reserves. Segelman is the author of "Take Action: Successful Australians Share their Secrets." (Lothian Books, 2004).

The company's board of advisors includes Andrea Hansen, jewelry marketing veteran and former president of the Women's Jewelry Association; Jeremy Avitan, CPA and compliance executive; Michael Lawrence corporate lawyer and litigator, Doug Cole, corporate financier and entrepreneur, Thierry Chaunu, a luxury goods executive with prior senior management roles at Chopard, Christofle and Cartier, and Pinny Gwinisch, founder of Ice.com and adjunct professor at McGill and Rutgers University. Disclaimer

Reign Sapphire Corp. Company Blog

Reign Sapphire Corp. News:

Reign Sapphire Corp. (RGNP) Offering Custom-Made Jewelry that’s Memorable and Conflict-Free

Reign Sapphire Corp. Coordinates Collection Expands with New Men's Line in Sterling Silver and 14K Gold

Reign Sapphire Corp. (RGNP) Delivers Conflict-Free Gems Directly to Consumers

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(DRNG) +44.79%

2.

Trader Power News
(ZSAN) +39.38%

3.

NetworkNewsWire
(IMLFF) +33.63%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251